In contrast, EMT6 (mammary carcinoma), EL4 (T lymphoblast), and Hepa1-6 (hepatoma) feature robust caspase-2 expression, much higher than in Jurkat cells (Fig. 5C). Here, CASP2 is linked to breast carcinoma.